119-hr2351

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2351 Referred in Senate

    (RFS) ]

<DOC>
119th CONGRESS
 1st Session
 H. R. 2351

_______________________________________________________________________

 IN THE SENATE OF THE UNITED STATES

 June 10, 2025

 Received; read twice and referred to the Committee on Commerce, 
 Science, and Transportation

_______________________________________________________________________

 AN ACT

To direct the Commandant of the Coast Guard to update the policy of the 
Coast Guard regarding the use of medication to treat drug overdose, and 
 for other purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CONTROLLED SUBSTANCE ONBOARD VESSELS.

 

Section 70503

    (a) of title 46, United States Code, is amended--

    (1) in the matter preceding paragraph

    (1) by striking 
 ``While on board a covered vessel, an'' and inserting ``An'';

    (2) by amending paragraph

    (1) to read as follows:
 ``

    (1) manufacture or distribute, possess with intent to 
 manufacture or distribute, or place or cause to be placed with 
 intent to manufacture or distribute a controlled substance on 
 board a covered vessel;'';

    (3) in paragraph

    (2) by inserting ``on board a covered 
 vessel'' before the semicolon; and

    (4) in paragraph

    (3) by inserting ``while on board a 
 covered vessel'' after ``such individual''.

SEC. 2. POLICY AND BRIEFING ON AVAILABILITY OF NALOXONE TO TREAT OPIOID 
 OVERDOSES.

    (a) 

=== Policy ===
-Not later than 1 year after the date of enactment of 
this Act, the Commandant of the Coast Guard shall update the policy of 
the Coast Guard regarding the use of medication to treat drug 
overdoses, including the use of naloxone or other similar medication to 
treat opioid, including fentanyl, overdoses.

    (b) Availability.--The updated policy required under subsection

    (a) shall require naloxone or other similar medication be available for 
members of the Coast Guard--

    (1) on all Coast Guard installations; and

    (2) in each operational environment.
            (c) Participation in Tracking System.--Not later than 1 year after 
the earlier of the date of enactment of this Act or the date on which 
the tracking system established under 

section 706 of the National 
Defense Authorization Act for Fiscal Year 2024 (10 U.S.C. 1090 note) is 
established, the Commandant shall ensure the participation of the Coast 
Guard in the such tracking system.
            (d) Memorandum of Understanding.--Not later than 1 year after the 
earlier of the date of enactment of this Act or the date on which the 
tracking system established under 

section 706 of the National Defense 
Authorization Act for Fiscal Year 2024 (10 U.S.C. 1090 note) is 
established, the Secretary of the department in which the Coast Guard 
is operating when not operating as a service in the Navy and the 
Secretary of Defense shall finalize a memorandum of understanding to 
facilitate Coast Guard access such tracking system.

    (e) Briefing.--

    (1) In general.--Not later than 2 years after the date of 
 enactment of this Act, the Commandant shall provide the 
 Committee on Transportation and Infrastructure of the House of 
 Representatives and the Committee on Commerce, Science, and 
 Transportation of the Senate a briefing on the use, by members 
 and personnel of the Coast Guard at Coast Guard facilities, 
 onboard Coast Guard assets, and during Coast Guard operations, 
 of--
        (A) naloxone or other similar medication to treat 
 opioid, including fentanyl, overdoses; and
        (B) opioids, including fentanyl.

    (2) Elements.--The briefing required under paragraph

    (1) shall include the following:
        (A) A description of--
            (i) the progress made in the implementation 
 of the updated policy required under subsection

    (a) ;
            (ii) the prevalence and incidence of the 
 illegal use of fentanyl and other controlled 
 substances in the Coast Guard during the 5-year 
 period preceding the briefing;
            (iii) processes of the Coast Guard to 
 mitigate substance abuse in the Coast Guard, 
 particularly with respect to fentanyl; and
            (iv) the status of the memorandum of 
 understanding required under subsection
            (d) .
        (B) For the 5-year period preceding the briefing, a 
 review of instances in which naloxone or other similar 
 medication was used to treat opioid, including 
 fentanyl, overdoses at a Coast Guard facility, onboard 
 a Coast Guard asset, or during a Coast Guard operation.

    (f) Privacy.--In carrying out the requirements of this section, the 
Commandant shall ensure compliance with all applicable privacy law, 
including 

section 552a of title 5, United States Code (commonly 
referred to as the ``Privacy Act''), and the privacy regulations 
promulgated under 

section 264
            (c) of the Health Insurance Portability 
and Accountability Act (42 U.S.C. 1320d-2 note).

    (g) Rule of Construction.--For purposes of the availability 
requirement under subsection

    (b) , with respect to a Coast Guard 
installation comprised of multiple Coast Guard facilities or units, 
naloxone or other similar medication available at a single Coast Guard 
facility within the installation shall be considered to be available to 
all Coast Guard facilities or units on the installation if appropriate 
arrangements are in place to ensure access, at all times during 
operations, to the naloxone or other similar medication contained 
within such single Coast Guard facility.

 Passed the House of Representatives June 9, 2025.

 Attest:

 KEVIN F. MCCUMBER,

 Clerk.